Re:NMDA Receptor Antagonists: Slightly More Than You Wanted ...
by OutOfHere on Wednesday July 30, 2025 @12:50PM
(#44736545)
Isn't DXM a disassociative at high doses? Moreover, don't people risk getting quite addicted to it, escalating their dose beyond even what you take? Perhaps your dose is stable, but even optimistically, it is management, not a cure. A cure is more possible with lower doses of DXM before it becomes a hard dependence.
[ Parent
| on HN ]
Re:NMDA Receptor Antagonists: Slightly More Than You Wanted ...
by pharmacoguy on Wednesday July 30, 2025 @03:18PM
(#44738415)
The bupropion (Wellbutrin) portion of the combination mentioned above serves as a CYP2D6 inhibitor as well, actually boosting the action of the DXM in the body. Auvelity dosing starts lower with just 45mg of DXM, jumping to 90mg as the tolerance curve starts to set in.
Re:NMDA Receptor Antagonists: Slightly More Than You Wanted ...
by trehalose on Wednesday July 30, 2025 @04:36PM
(#44739191)
CYP2D6 metabolizes DXM into a much more potent NMDA antagonist (dextrorphan, sometimes abbreviated to DXO). Inhibiting it boosts some action(s) of DXM but likely reduces the NMDA antagonist effect.
Re:NMDA Receptor Antagonists: Slightly More Than You Wanted ...
by curiouser3 on Wednesday July 30, 2025 @01:48PM
(#44737322)
wellbutrin+dxm is actually offered as a combination pill now (Auvelity)